DRS

Leonardo DRS, Inc. Common Stock

$48.41

+6.75%
May 28, 2026
Bobby Quantitative Model
Leonardo DRS, Inc. is a defense technology company that designs, develops, and manufactures advanced sensing, network computing, force protection, and electric power and propulsion solutions for land, air, sea, space, and cyber domains. The company operates as a critical, non-prime contractor within the U.S. defense industrial base, specializing in high-margin, technologically advanced subsystems and components. The current investor narrative is driven by strong quarterly earnings beats, robust forward guidance for 2026, and a favorable geopolitical backdrop that is fueling demand for defense technologies, as evidenced by recent news highlighting record highs for defense stocks amid escalating global tensions.

People also watch

GE Aerospace

GE Aerospace

GE

Analysis
RTX

RTX

RTX

Analysis
Boeing

Boeing

BA

Analysis
Lockheed Martin

Lockheed Martin

LMT

Analysis
Howmet Aerospace

Howmet Aerospace

HWM

Analysis

BobbyInvestment Opinion: Should I buy DRS Today?

Rating & Thesis: Hold. DRS is a high-quality defense growth story with excellent fundamentals, but its premium valuation fully reflects this optimism, limiting near-term upside and elevating risk. The bullish analyst consensus (recent upgrades to Buy) and strong guidance are acknowledged, but the risk/reward at current levels is balanced.

Supporting Evidence: The stock trades at a forward P/E of 32.7x, a significant premium that demands flawless execution. While Q4 revenue grew 8.05% YoY and net margin expanded to 9.62%, these improvements are already priced in. The company's financial strength is undeniable, with a debt-to-equity of 0.17 and $425M in Q4 operating cash flow, but these are stability factors, not immediate catalysts for multiple expansion. The implied upside is constrained by the stock's proximity to its 52-week high of $49.31, just 7% above the current price.

Risks & Conditions: The two biggest risks are growth deceleration and multiple compression. This Hold rating would upgrade to a Buy if the forward P/E compressed below 25x on non-fundamental weakness, or if the company posted consecutive quarters of revenue growth above 10% with sustained margin expansion. It would downgrade to Sell if revenue growth decelerated below 5% or if net margins contracted sequentially. The stock is currently fairly valued to slightly overvalued relative to its near-term growth prospects, trading at a premium justified only by continued perfect execution.

Sign up to view all

DRS 12-Month Price Forecast

The outlook for DRS is one of high quality but fully valued execution. The base case (60% probability) of range-bound trading is most likely, as the company is expected to deliver on its guidance but not sufficiently outperform to justify significant multiple expansion. The bull case requires a continuation of perfect quarterly beats in a favorable macro climate, while the bear case, though lower probability, carries a severe downside due to valuation risk. The stance would turn bullish on a pullback to a P/E in the mid-20s or evidence of accelerating growth; it would turn bearish on any crack in the growth or margin trajectory.

Historical Price
Current Price $48.41
Average Target $46.155
High Target $54
Low Target $32.43

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Leonardo DRS, Inc. Common Stock's 12-month outlook, with a consensus price target around $62.93 and implied upside of +30.0% versus the current price.

Average Target

$62.93

2 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

2

covering this stock

Price Range

$39 - $63

Analyst target range

Buy
0 (0%)
Hold
1 (50%)
Sell
1 (50%)

Analyst coverage is limited, with only 3 analysts providing estimates, which is typical for a mid-cap defense contractor and can lead to higher volatility and less efficient price discovery. The consensus sentiment is bullish, with recent institutional actions from firms like B of A Securities and Truist Securities maintaining 'Buy' ratings, and the average revenue estimate for the coming period is $5.05 billion. The target price range is not explicitly provided in the data, but the presence of recent 'Buy' ratings from multiple firms following strong earnings suggests a positive bias. The pattern of recent analyst actions shows stability, with no downgrades in the provided data and one upgrade from B of A Securities from Neutral to Buy in March 2025, indicating strengthening conviction in the company's outlook.

Drowning in data?

Find the real signal!

Bulls vs Bears: DRS Investment Factors

The bull case for DRS, anchored in accelerating fundamental performance, pristine financials, and powerful sector tailwinds, currently holds stronger evidence than the bear case. The sequential revenue growth, margin expansion, and massive operating cash flow generation are concrete, high-quality signals. However, the single most important tension in the investment debate is the stock's premium valuation (32.7x forward P/E) against the necessity for sustained high growth. The thesis hinges on whether DRS can continue to deliver quarterly beats and guide robustly to justify its multiple, or if even a modest deceleration triggers the valuation compression risk inherent in its trading history.

Bullish

  • Strong Revenue Growth & Momentum: Q4 2025 revenue grew 8.05% YoY to $1.06B, and sequential quarterly revenue increased from $799M in Q1 to $1.06B in Q4, demonstrating accelerating operational momentum. This growth is driven by the high-tech Advanced Sensing and Computing segment, which generated $509M in the latest period.
  • Robust Profitability & Margin Expansion: Net margin expanded to 9.62% in Q4 2025 from 7.5% in Q3, while gross margin improved to 24.81% from 23.13%. This demonstrates effective cost management and operating leverage, translating Q4 net income of $102M into a trailing P/E of 32.53x.
  • Exceptional Financial Strength & Cash Flow: The balance sheet is pristine with a low debt-to-equity ratio of 0.17 and a robust current ratio of 1.89. The company generated $425M in operating cash flow in Q4 alone, supporting a trailing FCF of $227M and reducing reliance on external financing.
  • Favorable Geopolitical & Sector Tailwinds: Recent news highlights defense stocks hitting record highs amid escalating global tensions. DRS's strong Q4 earnings beat and 2026 guidance, as reported, align with this sector-wide narrative, providing a powerful macro catalyst for sustained demand.

Bearish

  • Premium Valuation with Limited Upside: The stock trades at a forward P/E of 32.72x, a premium to its own historical median and likely to the broader Aerospace & Defense sector. This leaves little room for multiple expansion and prices in near-perfect execution, increasing vulnerability to disappointment.
  • Vulnerability to Growth Deceleration: The current premium P/E is predicated on continued high growth. Any slowdown in revenue growth from the current 8.05% YoY pace or margin expansion could trigger significant multiple compression, as seen in the stock's historical P/E swings from 11x to over 40x.
  • Limited Analyst Coverage & Liquidity Risk: Only 3 analysts cover the stock, which can lead to less efficient price discovery and higher volatility. Combined with a short ratio of 2.2, this indicates a concentrated and potentially sentiment-driven market for the shares.
  • Technical Overextension Near Resistance: The current price of $46.06 is near the upper end of its 52-week range, with immediate resistance at the 52-week high of $49.31. The recent 1-month pullback of -0.22% and a max drawdown of -32.8% highlight the stock's susceptibility to corrections after strong runs.

DRS Technical Analysis

The stock is in a sustained uptrend, evidenced by a 1-year price change of +35.63% and a current price of $46.06, which positions it at approximately 78% of its 52-week range ($32.43 to $49.31). This positioning near the upper end of the range suggests strong momentum but also raises the risk of overextension if the stock approaches its 52-week high. Recent momentum has been robust, with a 3-month gain of +12.37%, significantly outpacing the S&P 500's -2.1% return over the same period, indicating strong relative strength. However, the stock has pulled back slightly over the past month, declining -0.22%, which may represent a healthy consolidation within the broader uptrend rather than a reversal, especially given its low beta of 0.256, which implies it is far less volatile than the broader market. Key technical support is anchored at the 52-week low of $32.43, while immediate resistance lies at the 52-week high of $49.31. A decisive breakout above $49.31 would signal a continuation of the powerful uptrend, while a breakdown below the recent consolidation zone around $43 could suggest a deeper correction. The stock's exceptionally low beta of 0.256 indicates it has been a defensive holding, exhibiting only about a quarter of the market's volatility, which is unusual for a growth-oriented defense name and may reflect its stable, long-term contract profile.

Beta

0.03

0.03x market volatility

Max Drawdown

-32.8%

Largest decline past year

52-Week Range

$32-$49

Price range past year

Annual Return

+14.4%

Cumulative gain past year

PeriodDRS ReturnS&P 500
1m+20.5%+6.0%
3m+11.6%+10.0%
6m+41.7%+10.4%
1y+14.4%+28.4%
ytd+39.2%+10.7%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

DRS Fundamental Analysis

Revenue growth is accelerating, with Q4 2025 revenue of $1.06 billion representing an 8.05% year-over-year increase, and sequential quarterly revenue has grown from $799M in Q1 to $1.06B in Q4, indicating strong operational momentum. The Advanced Sensing and Computing segment, which generated $509 million in the latest period, is the primary growth driver, outpacing the Integrated Mission Systems segment's $383 million, highlighting the company's strength in high-tech defense electronics. Profitability is solid and improving, with Q4 2025 net income of $102 million and a net margin of 9.62%, up from 7.5% in Q3, while gross margin expanded to 24.81% in Q4 from 23.13% in Q3, demonstrating effective cost management and operating leverage. The company is solidly profitable with a trailing twelve-month free cash flow of $227 million, supporting a healthy free cash flow yield. The balance sheet is exceptionally strong, with a low debt-to-equity ratio of 0.17 and a robust current ratio of 1.89, indicating ample liquidity. The company generated $425 million in operating cash flow in Q4 alone, which comfortably funds its capital expenditures ($49M in Q4), dividends, and share repurchases, reducing reliance on external financing and minimizing financial risk.

Quarterly Revenue

$1.1B

2025-12

Revenue YoY Growth

+0.08%

YoY Comparison

Gross Margin

+0.24%

Latest Quarter

Free Cash Flow

$227000000.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Integrated Mission Systems Segment
Advanced Sensing And Computing Segment

Open an Account, get $2 TSLA now!

Valuation Analysis: Is DRS Overvalued?

Given a positive net income of $102 million in the latest quarter, the primary valuation metric is the P/E ratio. The stock trades at a trailing P/E of 32.53x and a forward P/E of 32.72x, with the minimal gap between the two suggesting the market has already priced in near-term earnings growth expectations. Compared to the broader Industrials/Aerospace & Defense sector, a trailing P/E in the low-30s likely represents a premium, which needs to be justified by the company's superior growth profile, margin expansion, and defensive characteristics in the current geopolitical climate. Historically, the stock's own trailing P/E has fluctuated significantly, from a low near 11x in late 2022 to highs above 40x in 2025; the current multiple of 32.5x sits above its multi-year median, indicating the market is pricing in optimistic expectations for continued execution and defense budget tailwinds, leaving less room for multiple expansion.

PE

32.5x

Latest Quarter

vs. Historical

Mid-Range

5-Year PE Range 1x~70x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

20.1x

Enterprise Value Multiple

Investment Risk Disclosure

Financial & Operational Risks: The primary financial risk is not solvency—given the strong balance sheet (D/E 0.17)—but valuation compression. The stock trades at a forward P/E of 32.7x, which is high for the sector and above its own median. This premium is entirely dependent on maintaining its recent 8%+ revenue growth and expanding margins; a single quarterly miss could precipitate a sharp derating. Furthermore, while diversification exists across domains, the company remains 100% exposed to government defense budgets, introducing cyclicality and political risk to its revenue stream.

Market & Competitive Risks: The key market risk is a sector rotation away from defense stocks if geopolitical tensions ease, removing a primary catalyst. The stock's low beta of 0.256 suggests it has been treated as a defensive holding, but this characteristic could reverse if growth expectations falter. Competitively, as a subsystem provider, DRS faces pressure from both prime contractors integrating capabilities in-house and other agile, tech-focused defense firms. The limited analyst coverage (3 firms) exacerbates these risks by making the stock more prone to sentiment swings and less efficiently priced.

Worst-Case Scenario: The worst-case scenario involves a combination of a defense budget scare, a quarterly earnings miss that breaks the growth narrative, and a broader market downturn. This could trigger a rapid derating from the current 32.7x P/E towards its historical low near 11x. A realistic downside target would be a retest of the 52-week low of $32.43, representing a potential loss of approximately -30% from the current price of $46.06. The stock's historical max drawdown of -32.8% provides a precedent for this magnitude of decline during periods of negative sentiment.

FAQ

The key risks are: 1) Valuation Compression: The high P/E (32.7x) is the biggest risk; earnings disappointment could trigger a sharp decline. 2) Growth Dependency: Revenue growth must remain robust to justify the premium; deceleration below 5% YoY would be damaging. 3) Sector Cyclicality: Despite current tailwinds, the business is tied to U.S. defense budgets, which are subject to political cycles. 4) Limited Coverage: With only 3 analysts, the stock is more susceptible to sentiment swings and less liquid price discovery, as indicated by a short ratio of 2.2.

The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock trading between $43 and $49.31, as it meets growth expectations but sees no multiple expansion. The Bull Case (25% probability) targets $49.31 to $54, requiring earnings beats and sector momentum to drive the price above resistance. The Bear Case (15% probability) warns of a drop to $32.43-$38 if growth stumbles, triggering multiple compression. The Base Case is most likely, centered on the company delivering on its $5.05B revenue guidance without major surprises.

DRS is fairly valued to slightly overvalued. Its forward P/E of 32.7x is a premium multiple that reflects its recent 8.05% revenue growth and margin expansion. Compared to its own history, where the P/E has ranged from ~11x to over 40x, the current multiple is above the median, suggesting the market is pricing in continued strong execution. The valuation implies the market expects DRS to maintain high-single-digit growth and expanding profitability; any deviation from this path would likely lead to a downward valuation correction.

DRS is a good stock for investors who already believe in the long-term defense spending thesis and are seeking a well-run, financially sound operator. However, at a forward P/E of 32.7x, it is not a compelling buy for new money at current prices. The ~7% upside to its 52-week high is modest relative to the ~30% downside risk to its 52-week low if the growth narrative stumbles. It is a good buy on a significant pullback (e.g., below $40) for long-term holders, but a 'Hold' for those already invested.

DRS is primarily suitable for a long-term investment horizon of 3-5 years. Its low beta (0.256) and stable contract-based revenue provide defensive characteristics, while its growth trajectory requires time to compound. The stock is less ideal for short-term trading due to its limited analyst coverage, which can cause gaps around earnings, and its current position near 52-week highs, which limits near-term upside. Investors should be prepared to hold through potential volatility related to quarterly earnings and budget cycles to capture the long-term growth story.